Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moulin

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Atherosclerosis|October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyJ Koizumi, A Inazu, K Yagi, et al.
Thrombosis and Haemostasis|April 3, 2015
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patientsE Véricel, R Colas, C Calzada, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1993
Exercise training decreases plasma cholesteryl ester transfer proteinR L Seip, P Moulin, T Cocke, et al.
The Journal of Biological Chemistry|June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic miceL B Agellon, A Walsh, T Hayek, et al.
The British Journal of Ophthalmology|November 23, 2012
Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastomaNandan G Shetye, Asimina Mataftsi, Philippe Maeder, et al.
Pigment Cell & Melanoma Research|March 18, 2014
Notch signaling in the pigmented epithelium of the anterior eye segment promotes ciliary body development at the expense of iris formationBhushan Sarode, Craig S Nowell, JongEun Ihm, et al.
AIDS Care|May 29, 2000
Modalities of palliative care in hospitalized patients with advanced AIDSI Vincent, D D'Hérouville, P Moulin, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Ineffectiveness of lipid-lowering therapy in primary careE Van Ganse, T Souchet, L Laforest, et al.
Atherosclerosis|July 26, 2005
Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational studyE Van Ganse, T Souchet, L Laforest, et al.
Diabetes & Metabolism|January 20, 2009
Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18 to 34-week, open-label, extension periodP Moulin, M André, H Alawi, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Atherosclerosis|October 1, 1991
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyJ Koizumi, A Inazu, K Yagi, et al.
Thrombosis and Haemostasis|April 3, 2015
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patientsE Véricel, R Colas, C Calzada, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1993
Exercise training decreases plasma cholesteryl ester transfer proteinR L Seip, P Moulin, T Cocke, et al.
The Journal of Biological Chemistry|June 15, 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic miceL B Agellon, A Walsh, T Hayek, et al.
The British Journal of Ophthalmology|November 23, 2012
Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastomaNandan G Shetye, Asimina Mataftsi, Philippe Maeder, et al.
Pigment Cell & Melanoma Research|March 18, 2014
Notch signaling in the pigmented epithelium of the anterior eye segment promotes ciliary body development at the expense of iris formationBhushan Sarode, Craig S Nowell, JongEun Ihm, et al.
AIDS Care|May 29, 2000
Modalities of palliative care in hospitalized patients with advanced AIDSI Vincent, D D'Hérouville, P Moulin, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Ineffectiveness of lipid-lowering therapy in primary careE Van Ganse, T Souchet, L Laforest, et al.
Atherosclerosis|July 26, 2005
Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational studyE Van Ganse, T Souchet, L Laforest, et al.
Diabetes & Metabolism|January 20, 2009
Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18 to 34-week, open-label, extension periodP Moulin, M André, H Alawi, et al.
Pageof 19